GLP-1s for Antipsychotic Weight Gain: 2026 PMHNP Guide
Semaglutide cut 19 lbs and HbA1c 0.25% in patients on clozapine and olanzapine. Here is how PMHNPs use GLP-1s for antipsychotic weight gain in 2026.
Real talk about psychopharmacology, clinical confidence, and building a practice you love — from Lindsay and the Fellowship faculty.
More Articles
Semaglutide cut 19 lbs and HbA1c 0.25% in patients on clozapine and olanzapine. Here is how PMHNPs use GLP-1s for antipsychotic weight gain in 2026.
A 2026 JAMA Psychiatry RCT found clozapine outperformed second-line options after one failed antipsychotic in first-episode psychosis. Here's what PMHNPs should know about early clozapine use, post-REMS monitoring, and building prescribing confidence.
The FDA has streamlined clozapine REMS requirements for 2026, reducing ANC monitoring frequency for established patients while maintaining safety...